Search Results

2022 Participants Explore participated startups 3D+ 3D+ aims to cover the absence of digital surgical planning and 3D printing services in the healthcare sector within the entire region, by utilizing its expertise and technology (Additive manufacturing & AI artificial intelligence) throughout surgery, Education, research and humanitarian. AFRAD-OMICS Building up a screening & diagnostic program using big data & incremental AI approach to reach accurate detection & predication of the disease which designed to be accessible and affordable for both genders to improve quality of life, decrease community, social & economic burden of late diagnosis. Arab Medical Innovations Contactless, non-intrusive alert device that automatically detects a patient that is in need of medical attention and alerts first responders immediately. The device is designed to detect abnormal behavior such as prolonged lack of activity or detect a fall or a patient laying on the ground and trigger an automatic alarm accordingly. BEEKEEPER TECH W.L.L Our food security and agricultural biodiversity, are threatened due to tremendous losses of bee colonies worldwide during the last decade. Beekeepers raise their beehives in the mountains and on farms. They can rarely fix problems at an early stage. For these reasons, we devolved the SmartBee device. It can record and transmit the hives’ data to monitor the health and production of colonies. Using the collected data and specific Genetic Breeding Value modelling, we can select colonies with the best genetic strains for better resiliency and productivity in their local environment. Cambridge Nucleomics Cambridge Nucleomics is solving major problems in RNA drug development by using a cutting-edge technology that combines DNA nanotechnology and nanopore sensing to analyse RNA target and drugs in a revolutionary way. CassaGro Biosytems Indonesia First Indonesia company operates fully integrated bioconversion from cassava genetic improvement, regenerative farming, value added processing, and waste recycling. Refer to ecological balance; we strive to prioritize the transformation process in every production line to maximize the value as well as zero-waste production. Involving insect in bioconversion to produce sustainable protein source for animal feed and combined with cassava we are able to produce a low cost of fish and poultry Cyborg We are a prosthetic and splints manufacturer by 3d printing, we have the knowledge and the experience and the ability to make any type of splints or prosthetics for any case. Digital Health KSA Digital Solution for measuring arterial stiffness Glucose Biosensors Glucose Biosensors provide innovative solutions to non-invasively measure and monitor Glucose level in the blood. Green Desert Green Desert is a biotechnology Saudi Arabian start-up company founded in January 2020. Green Desert aims to heal the ecological issues of Saudi Arabia and the gulf countries. GD's ultimate goal is to eliminate the vicious circle occurring in Saudi Arabia and the region. The company envisioned becoming the premier and preferred leading Cannabis sativa-based products provider in the MENA province. Haven Scientific "Haven Scientific is a local registered company specialized in designing and manufacturing molecular biology kits, such as DNA/RNA extraction kits and PCR assays (gene expression, genotyping, pathogen detection, etc.). Haven Scientific is the first of its kind in the Middle East and North Africa.". Hypoguard Biotechnology We're rising to the clean Water, Sanitation and Hygiene (W.A.S.H) challenges across Sub Saharan Africa, the world's final frontier. Our solution is Electrochemical Activation Technology; this converts salt, water and an electro charge into a safe, potent and highly sustainable biocide. The result is broad spectrum impact in healthcare, agro, food processing and on demand water treatment. Humanity's greatest sanitation and hygiene challenges come from Africa - Hypoguard is creating a localised and high impact solution. Kinimmune, Inc. Cancer is the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Kinimmune is a clinical-stage biotechnology company discovering and developing quick-to-market intratumoral immunostimulants for unlocking the full potential of checkpoint inhibition in solid tumors. Kinimmune is the first Saudi American biotech company whose cancer therapy reached the clinical stages in the United States of America after obtaining the approval of the US Food and Drug Administration (FDA) to start the phase I clinical trial (NCT03982212). With extensive team experience in biotechnology between Saudi Arabia (King Abdulaziz University) and the United States (The University of Kansas), we’re working to harness the immune system's potential to fight cancer. Labop Logistics digital platform system that facilitate the request of the client in laboratory tests and services, throughout online request for the specific test and service. Labop will arrange the pick up and return the result back to the client with specific codes. LivingCells Theraputics Manufacturing of cellular immunotherapies; chimeric antigen receptor (CAR) CAR-T cell therapies; as medicinal tools to fight against cancer. MBioSurTen Biodegradable and environmentally friendly surfactants to replace chemical surfactants used for cleaning detergents and surface tension reducing agents. Nano Fabrics A local startup that invented a technology where we could take any cotton based textile, and apply our patented nano technology coating approach to that textile, which converts that textile into a textile that prevents microbial growth NanoPalm Develop a gene editing therapeutic nanorobot for patients with Sickle Cell Disease. It relies on artificial intelligence-enabled lipid nanoparticles called �Nanopalm�, which is being trialed at the National Guard Hospital, Riyadh, to perform a single base editing to erase SCD in a safer, affordable, and more efficient route. Noor Diagnostics and Discovery NoorDx is a biotechnology company focused on providing localized capacity and expertise to support and advance utilization of genomics‭ ‬in the healthcare and R&D sectors. Novai Ltd Novai is a British biotechnology start-up, developing DARC (Detection of Apoptosing Retinal Cells), an approved exploratory biomarker by FDA, MHRA and TGA for use in Age-related Macular Degeneration, Glaucoma and other clinical studies. DARC combines an innovative patented biologic with a state-of-the-art AI algorithm and uses standard imaging equipment to identify cellular level disease activity. Novai intends to bring DARC to market as a diagnostic and therapy prognosis, as a first indication, with opportunities for novel expansion of DARC as a targeted drug delivery vehicle which can overcome biological barriers known to impede drug delivery to eye and brain. OPTIMA-DX OPTIMA-Dx is building next-generation Point-Of-Care and At-home diagnostics for viral and bacterial pathogens and genetic disease markers to improve human health. More than half of the population lacks access to timely and accurate diagnostics. And existing molecular diagnostics infrastructure is limited to reliable but centralized products or point-of-care but unreliable products. We solve this diagnostic gap. Powered by our proprietary CRISPR biotechnologies, our OPTIMA-Dx platform makes accurate, sensitive, specific, user-friendly, and affordable diagnostics tests accessible to people at the point-of-care or at-home. We are a diverse team of experts spinning out from KAUST, and our vision is to advance healthcare accessibility through decentralizing precision diagnostics. OPTIMA-Dx makes diagnostics accessible to everyone everywhere to improve human health and the quality of life. Plansulin Plansulin intends to disrupt the insulin market by developing cheaper insulin from transgenic plants. Previous experiments have demonstrated the feasibility of using transgenic plants to manufacture recombinant insulin at commercial scale. Global Human Insulin Market is estimated to be US$ 40 Billion and growing at a 7.6% CAGR. The demand for insulin looks set to rise. Led by increasing incidence of the disease, and oral delivery. Pilot MVP product will be ready by Q1 2023. Full-scale batches will then be produced prior to clinical trial production leading to product registration and approval by 2025, 100% manufactured in Saudi Arabia. Proteinea Proteinea - a biotech company engineering proteins to tackle life-threatening diseases. The Artificial intelligence platform for biotherapeutics engineering along with the novel production process promises innovative therapeutic modalities accessible to everyone. RedSeaBioTik Local biotech company that provide high quality recombinant proteins and diagnostic kits for medical and research purposes in local and regional markets Rubiks Omics Rubiks Omics is a next-generation sequencing startup company specializing in designing and running bespoke genetic tests to enable clinicians to choose the right treatment for patients of Arab ancestry. Our mission is to utilize genomics to develop IP-protected genomics tests, starting with cancer. We leverage our genomic database obtained from patients from the Middle East and North Africa, and partner with major biotech companies like Illumina and world-class genomic facilities like UCL Genomics in England to establish our facility and rapid testing workflow. We aim to change the lives of millions of Arab patients yearly through improved personalised care. Sci-Insights AI Sci-Insights AI is a bioinformatic SaaS company for research labs. Biologists use it to rapidly analyze and plot RNA-seq data, without the need to code in R or Python! Shomool The landscape of genetic disease in Saudi Arabia specifically is known to be dominated by autosomal recessive disorders because of the highly consanguineous nature of this population. Additionally, it also has been shown that because of this population characteristic, there is a higher occurrence of recessive, typically homozygous, mutations causing genetic disease, we present a comprehensive approach for noninvasive prenatal screening applicable for autosomal recessive conditions (ShomoolTM), based on cffDNA next-generation sequencing. SilicoLife AI + Biology for sustainable chemicals SilicoLife designs optimized microorganisms and novel pathways for industrial biotechnology applications, based on artificial intelligence and synthetic biology approaches, shortening the development time and costs of new highly effective processes for the production of specific target compounds such as chemicals, food ingredients or biopolymers. The Editing Currently, there are about 7500 genetic disorders, most of them are lethal and incurable. Gene editing is the main hope for the patients. However, gene editing tools have limitations. The Editing discovered a natural human protein that in coordination with CRISPR/cas system can produce precise DNA edits of up to 30 bp thus capable of treating 89% of all genetic disorders. Vetting Technologies Fast, Low-cost, high-quality testing applications for camels. Our Partners To play, press and hold the enter key. To stop, release the enter key.

About The Program Registration Beneficiaries Objectives Frequently asked questions Do I need to have a team to participate in the program? No, you can participate as an individual or with a team. Why participating in the program is important? To obtain the best training and consultancies by elite specialists. Also, to obtain the financial support for the biotechnology investment. What are the conditions to qualify for the program? The applicant must have an established startup or proposal (idea) that he/she want to make it startups related to one of the biotechnology fields. Do I have to be present on site during the program's activities? No, the program's activities will be conducted on site and remotely simultaneously. Is the program limited to Saudi applicants only? No, the program is available for registration from inside and outside Saudi Arabia and for all nationalities. Who are the targets to be registered in the program? The program targets various sectors and individuals, including entrepreneurs, investors, medical employees, and those interested in biotechnology. Still, have other questions? contact us Address King Faisal Road, Dammam 34212 Phone 123-456-7890 Email info@dammamvalley.sa Connect

GET IN TOUCH We'd love to hear from you Find A Job Be a Volunteer Have a Question, Concern, Suggestion Have a project, a startup pr an idea? Subscribe to Our Newsletter Enter your email here Sign Up Thanks for submitting!

Item List

< Back Dr. Abdulwahed Al Mazru B ​ ​

< Back Entering a new era of IoT Derek Wells Mar 18, 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. This is placeholder text. To change this content, double-click on the element and click Change Content. Want to view and manage all your collections? Click on the Content Manager button in the Add panel on the left. Here, you can make changes to your content, add new fields, create dynamic pages and more. Your collection is already set up for you with fields and content. Add your own content or import it from a CSV file. Add fields for any type of content you want to display, such as rich text, images, and videos. Be sure to click Sync after making changes in a collection, so visitors can see your newest content on your live site. Previous Next

< Back Dr. Fahad Al-Muhanna D ​ ​

Time Out This page isn’t available right now. But we’re working on a fix, ASAP. Try again soon. Go Back

< Back Dr. Abdulkarim Alhowaish A ​ ​

First Name Last Name Email Phone Choose an option Choose an option Resume Upload File Send

Volunteering Form First Name Last Name Email Phone Voulteer in Choose an option How will you voulnteer? Physically Online Are you a student? Yes No Upload File Upload supported file (Max 15MB) Enter URL Submit Thanks for submitting! we will contact you soon

Second Phase Workshops Client: ​ Year: 2022 ​ Previous Next